Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study

Key Points

• The study aims to assess the safety and efficacy of intravenous golimumab in adults with ankylosing spondylitis.
• Administered golimumab intravenously to adults with ankylosing spondylitis.
• Monitored clinical outcomes through Week 28.
• Utilized specific indices for assessing disease metrics.
• Encountered data errors related to the Bath Ankylosing Spondylitis Metrology Index.
• Provided corrections for both tabular and in-text findings.